Legacy Education Earnings Call Transcripts
Fiscal Year 2026
-
Record fiscal 2026 results featured 24.8% revenue growth, margin expansion, and strong cash position. Growth is expected from new programs, Houston campus, and potential acquisitions, with disciplined capital allocation and continued demand in healthcare education.
-
Q3 delivered record revenue and profitability, driven by expanded healthcare programs, improved retention, and disciplined growth investments. Facility expansions and new programs are ramping, with strong demand from both students and employers.
-
Q2 saw revenue up 40.7% to $19.2M, Adjusted EBITDA up 61.6%, and net income up 46% to $2M, driven by strong enrollment and new program launches. Strategic expansion, robust liquidity, and continued investment in hybrid models position the company for further growth.
-
Q1 fiscal 2026 delivered 38.5% revenue growth, record enrollment, and strong net income, driven by high demand for allied health programs. Strategic investments and new program approvals set the stage for continued margin expansion and growth, with a robust balance sheet supporting M&A.
Fiscal Year 2025
-
Fiscal 2025 delivered record revenue and net income growth, driven by strong enrollment and new program launches. Strategic expansions, robust balance sheet, and operational innovation position the company for continued success in a high-demand healthcare education sector.
-
Q3 2025 saw record revenue growth of 50.7% year-over-year, driven by strong enrollment and the Contra Costa acquisition. Net income rose 57.1% to $2.8 million, with robust cash flow and continued expansion in high-demand healthcare programs.
-
Q2 2025 delivered 29.2% revenue growth and 8.5% net income growth year-over-year, driven by robust enrollment, new program launches, and the Contra Costa Medical Career College acquisition. Cash reserves remain strong, and demand for healthcare programs continues to rise.
-
Revenue grew 35% year-over-year to $14M, with net income up 95% to $2.1M and record student enrollment. IPO raised $11.5M, supporting expansion and new program launches, while the upcoming Contra Costa acquisition will add 14 Allied Health programs.